Integra LifeSciences Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Integra LifeSciences (IART) Tops Q1 EPS by 12c, Updates Guidance
April 28, 2021 6:13 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.69, $0.12 better than the analyst estimate of $0.57. Revenue for the quarter came in at $360.1 million versus the consensus estimate of $349.81 million.
GUIDANCE:
Integra LifeSciences sees FY2021 EPS of $2.86-$2.93, versus the consensus of $2.90.... More
Integra LifeSciences (IART) Tops Q1 EPS by 12c, Updates Guidance
April 28, 2021 6:13 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.69, $0.12 better than the analyst estimate of $0.57. Revenue for the quarter came in at $360.1 million versus the consensus estimate of $349.81 million.
GUIDANCE:
Integra LifeSciences sees FY2021 EPS of $2.86-$2.93, versus the consensus of $2.90.... More



